COVID-19 Impact on Global Heart Failure Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 133 pages | ID: C0987ECB49DDEN
QYResearch

Abstracts

This report focuses on the global Heart Failure Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Heart Failure Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Novartis
• Merck
• Sanofi
• Johnson & Johnson
• AstraZeneca
• GlaxoSmithKline
• Amgen
• Bayer
• BMS
• Cardiorentis
• Cytokinetics
• Ono Pharmaceuticals
• Mylan
• NCPC
• Xinhua Group
• Xudong Haipu Pharmaceutical

Market segment by Type, the product can be split into

• Drug Treatment
• Surgical Treatment

Market segment by Application, split into

• Acute Heart Failure
• Chronic Heart Failure

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Heart Failure Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Heart Failure Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Heart Failure Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Heart Failure Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Heart Failure Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drug Treatment
  1.4.3 Surgical Treatment
1.5 Market by Application
  1.5.1 Global Heart Failure Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Acute Heart Failure
  1.5.3 Chronic Heart Failure
1.6 Coronavirus Disease 2019 (Covid-19): Heart Failure Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Heart Failure Treatment Industry
    1.6.1.1 Heart Failure Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Heart Failure Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Heart Failure Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Heart Failure Treatment Market Perspective (2015-2026)
2.2 Heart Failure Treatment Growth Trends by Regions
  2.2.1 Heart Failure Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Heart Failure Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Heart Failure Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Heart Failure Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Heart Failure Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Heart Failure Treatment Players by Market Size
  3.1.1 Global Top Heart Failure Treatment Players by Revenue (2015-2020)
  3.1.2 Global Heart Failure Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Heart Failure Treatment Market Concentration Ratio
  3.2.1 Global Heart Failure Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Heart Failure Treatment Revenue in 2019
3.3 Heart Failure Treatment Key Players Head office and Area Served
3.4 Key Players Heart Failure Treatment Product Solution and Service
3.5 Date of Enter into Heart Failure Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Heart Failure Treatment Historic Market Size by Type (2015-2020)
4.2 Global Heart Failure Treatment Forecasted Market Size by Type (2021-2026)

5 HEART FAILURE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Heart Failure Treatment Market Size by Application (2015-2020)
5.2 Global Heart Failure Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Heart Failure Treatment Market Size (2015-2020)
6.2 Heart Failure Treatment Key Players in North America (2019-2020)
6.3 North America Heart Failure Treatment Market Size by Type (2015-2020)
6.4 North America Heart Failure Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Heart Failure Treatment Market Size (2015-2020)
7.2 Heart Failure Treatment Key Players in Europe (2019-2020)
7.3 Europe Heart Failure Treatment Market Size by Type (2015-2020)
7.4 Europe Heart Failure Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Heart Failure Treatment Market Size (2015-2020)
8.2 Heart Failure Treatment Key Players in China (2019-2020)
8.3 China Heart Failure Treatment Market Size by Type (2015-2020)
8.4 China Heart Failure Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Heart Failure Treatment Market Size (2015-2020)
9.2 Heart Failure Treatment Key Players in Japan (2019-2020)
9.3 Japan Heart Failure Treatment Market Size by Type (2015-2020)
9.4 Japan Heart Failure Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Heart Failure Treatment Market Size (2015-2020)
10.2 Heart Failure Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Heart Failure Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Heart Failure Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Heart Failure Treatment Market Size (2015-2020)
11.2 Heart Failure Treatment Key Players in India (2019-2020)
11.3 India Heart Failure Treatment Market Size by Type (2015-2020)
11.4 India Heart Failure Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Heart Failure Treatment Market Size (2015-2020)
12.2 Heart Failure Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Heart Failure Treatment Market Size by Type (2015-2020)
12.4 Central & South America Heart Failure Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Heart Failure Treatment Introduction
  13.1.4 Pfizer Revenue in Heart Failure Treatment Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Heart Failure Treatment Introduction
  13.2.4 Novartis Revenue in Heart Failure Treatment Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Merck
  13.3.1 Merck Company Details
  13.3.2 Merck Business Overview and Its Total Revenue
  13.3.3 Merck Heart Failure Treatment Introduction
  13.3.4 Merck Revenue in Heart Failure Treatment Business (2015-2020)
  13.3.5 Merck Recent Development
13.4 Sanofi
  13.4.1 Sanofi Company Details
  13.4.2 Sanofi Business Overview and Its Total Revenue
  13.4.3 Sanofi Heart Failure Treatment Introduction
  13.4.4 Sanofi Revenue in Heart Failure Treatment Business (2015-2020)
  13.4.5 Sanofi Recent Development
13.5 Johnson & Johnson
  13.5.1 Johnson & Johnson Company Details
  13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.5.3 Johnson & Johnson Heart Failure Treatment Introduction
  13.5.4 Johnson & Johnson Revenue in Heart Failure Treatment Business (2015-2020)
  13.5.5 Johnson & Johnson Recent Development
13.6 AstraZeneca
  13.6.1 AstraZeneca Company Details
  13.6.2 AstraZeneca Business Overview and Its Total Revenue
  13.6.3 AstraZeneca Heart Failure Treatment Introduction
  13.6.4 AstraZeneca Revenue in Heart Failure Treatment Business (2015-2020)
  13.6.5 AstraZeneca Recent Development
13.7 GlaxoSmithKline
  13.7.1 GlaxoSmithKline Company Details
  13.7.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.7.3 GlaxoSmithKline Heart Failure Treatment Introduction
  13.7.4 GlaxoSmithKline Revenue in Heart Failure Treatment Business (2015-2020)
  13.7.5 GlaxoSmithKline Recent Development
13.8 Amgen
  13.8.1 Amgen Company Details
  13.8.2 Amgen Business Overview and Its Total Revenue
  13.8.3 Amgen Heart Failure Treatment Introduction
  13.8.4 Amgen Revenue in Heart Failure Treatment Business (2015-2020)
  13.8.5 Amgen Recent Development
13.9 Bayer
  13.9.1 Bayer Company Details
  13.9.2 Bayer Business Overview and Its Total Revenue
  13.9.3 Bayer Heart Failure Treatment Introduction
  13.9.4 Bayer Revenue in Heart Failure Treatment Business (2015-2020)
  13.9.5 Bayer Recent Development
13.10 BMS
  13.10.1 BMS Company Details
  13.10.2 BMS Business Overview and Its Total Revenue
  13.10.3 BMS Heart Failure Treatment Introduction
  13.10.4 BMS Revenue in Heart Failure Treatment Business (2015-2020)
  13.10.5 BMS Recent Development
13.11 Cardiorentis
  10.11.1 Cardiorentis Company Details
  10.11.2 Cardiorentis Business Overview and Its Total Revenue
  10.11.3 Cardiorentis Heart Failure Treatment Introduction
  10.11.4 Cardiorentis Revenue in Heart Failure Treatment Business (2015-2020)
  10.11.5 Cardiorentis Recent Development
13.12 Cytokinetics
  10.12.1 Cytokinetics Company Details
  10.12.2 Cytokinetics Business Overview and Its Total Revenue
  10.12.3 Cytokinetics Heart Failure Treatment Introduction
  10.12.4 Cytokinetics Revenue in Heart Failure Treatment Business (2015-2020)
  10.12.5 Cytokinetics Recent Development
13.13 Ono Pharmaceuticals
  10.13.1 Ono Pharmaceuticals Company Details
  10.13.2 Ono Pharmaceuticals Business Overview and Its Total Revenue
  10.13.3 Ono Pharmaceuticals Heart Failure Treatment Introduction
  10.13.4 Ono Pharmaceuticals Revenue in Heart Failure Treatment Business (2015-2020)
  10.13.5 Ono Pharmaceuticals Recent Development
13.14 Mylan
  10.14.1 Mylan Company Details
  10.14.2 Mylan Business Overview and Its Total Revenue
  10.14.3 Mylan Heart Failure Treatment Introduction
  10.14.4 Mylan Revenue in Heart Failure Treatment Business (2015-2020)
  10.14.5 Mylan Recent Development
13.15 NCPC
  10.15.1 NCPC Company Details
  10.15.2 NCPC Business Overview and Its Total Revenue
  10.15.3 NCPC Heart Failure Treatment Introduction
  10.15.4 NCPC Revenue in Heart Failure Treatment Business (2015-2020)
  10.15.5 NCPC Recent Development
13.16 Xinhua Group
  10.16.1 Xinhua Group Company Details
  10.16.2 Xinhua Group Business Overview and Its Total Revenue
  10.16.3 Xinhua Group Heart Failure Treatment Introduction
  10.16.4 Xinhua Group Revenue in Heart Failure Treatment Business (2015-2020)
  10.16.5 Xinhua Group Recent Development
13.17 Xudong Haipu Pharmaceutical
  10.17.1 Xudong Haipu Pharmaceutical Company Details
  10.17.2 Xudong Haipu Pharmaceutical Business Overview and Its Total Revenue
  10.17.3 Xudong Haipu Pharmaceutical Heart Failure Treatment Introduction
  10.17.4 Xudong Haipu Pharmaceutical Revenue in Heart Failure Treatment Business (2015-2020)
  10.17.5 Xudong Haipu Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Heart Failure Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Heart Failure Treatment Revenue
Table 3. Ranking of Global Top Heart Failure Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Heart Failure Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug Treatment
Table 6. Key Players of Surgical Treatment
Table 7. COVID-19 Impact Global Market: (Four Heart Failure Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Heart Failure Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Heart Failure Treatment Players to Combat Covid-19 Impact
Table 12. Global Heart Failure Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Heart Failure Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Heart Failure Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Heart Failure Treatment Market Share by Regions (2015-2020)
Table 16. Global Heart Failure Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Heart Failure Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Heart Failure Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Heart Failure Treatment Players
Table 23. Global Heart Failure Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Heart Failure Treatment Market Share by Players (2015-2020)
Table 25. Global Top Heart Failure Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Treatment as of 2019)
Table 26. Global Heart Failure Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Heart Failure Treatment Product Solution and Service
Table 29. Date of Enter into Heart Failure Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Heart Failure Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Heart Failure Treatment Market Size Share by Type (2015-2020)
Table 33. Global Heart Failure Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Heart Failure Treatment Market Size Share by Application (2015-2020)
Table 35. Global Heart Failure Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Heart Failure Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Heart Failure Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Heart Failure Treatment Market Share (2019-2020)
Table 39. North America Heart Failure Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Heart Failure Treatment Market Share by Type (2015-2020)
Table 41. North America Heart Failure Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Heart Failure Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Heart Failure Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Heart Failure Treatment Market Share (2019-2020)
Table 45. Europe Heart Failure Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Heart Failure Treatment Market Share by Type (2015-2020)
Table 47. Europe Heart Failure Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Heart Failure Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Heart Failure Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Heart Failure Treatment Market Share (2019-2020)
Table 51. China Heart Failure Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Heart Failure Treatment Market Share by Type (2015-2020)
Table 53. China Heart Failure Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Heart Failure Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Heart Failure Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Heart Failure Treatment Market Share (2019-2020)
Table 57. Japan Heart Failure Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Heart Failure Treatment Market Share by Type (2015-2020)
Table 59. Japan Heart Failure Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Heart Failure Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Heart Failure Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Heart Failure Treatment Market Share (2019-2020)
Table 63. Southeast Asia Heart Failure Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Heart Failure Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Heart Failure Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Heart Failure Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Heart Failure Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Heart Failure Treatment Market Share (2019-2020)
Table 69. India Heart Failure Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Heart Failure Treatment Market Share by Type (2015-2020)
Table 71. India Heart Failure Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Heart Failure Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Heart Failure Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Heart Failure Treatment Market Share (2019-2020)
Table 75. Central & South America Heart Failure Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Heart Failure Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Heart Failure Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Heart Failure Treatment Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Product
Table 102. Johnson & Johnson Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 103. Johnson & Johnson Recent Development
Table 104. AstraZeneca Company Details
Table 105. AstraZeneca Business Overview
Table 106. AstraZeneca Product
Table 107. AstraZeneca Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 108. AstraZeneca Recent Development
Table 109. GlaxoSmithKline Company Details
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline Product
Table 112. GlaxoSmithKline Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 113. GlaxoSmithKline Recent Development
Table 114. Amgen Business Overview
Table 115. Amgen Product
Table 116. Amgen Company Details
Table 117. Amgen Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 118. Amgen Recent Development
Table 119. Bayer Company Details
Table 120. Bayer Business Overview
Table 121. Bayer Product
Table 122. Bayer Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 123. Bayer Recent Development
Table 124. BMS Company Details
Table 125. BMS Business Overview
Table 126. BMS Product
Table 127. BMS Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 128. BMS Recent Development
Table 129. Cardiorentis Company Details
Table 130. Cardiorentis Business Overview
Table 131. Cardiorentis Product
Table 132. Cardiorentis Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 133. Cardiorentis Recent Development
Table 134. Cytokinetics Company Details
Table 135. Cytokinetics Business Overview
Table 136. Cytokinetics Product
Table 137. Cytokinetics Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 138. Cytokinetics Recent Development
Table 139. Ono Pharmaceuticals Company Details
Table 140. Ono Pharmaceuticals Business Overview
Table 141. Ono Pharmaceuticals Product
Table 142. Ono Pharmaceuticals Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 143. Ono Pharmaceuticals Recent Development
Table 144. Mylan Company Details
Table 145. Mylan Business Overview
Table 146. Mylan Product
Table 147. Mylan Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 148. Mylan Recent Development
Table 149. NCPC Company Details
Table 150. NCPC Business Overview
Table 151. NCPC Product
Table 152. NCPC Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 153. NCPC Recent Development
Table 154. Xinhua Group Company Details
Table 155. Xinhua Group Business Overview
Table 156. Xinhua Group Product
Table 157. Xinhua Group Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 158. Xinhua Group Recent Development
Table 159. Xudong Haipu Pharmaceutical Company Details
Table 160. Xudong Haipu Pharmaceutical Business Overview
Table 161. Xudong Haipu Pharmaceutical Product
Table 162. Xudong Haipu Pharmaceutical Revenue in Heart Failure Treatment Business (2015-2020) (Million US$)
Table 163. Xudong Haipu Pharmaceutical Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Heart Failure Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drug Treatment Features
Figure 3. Surgical Treatment Features
Figure 4. Global Heart Failure Treatment Market Share by Application: 2020 VS 2026
Figure 5. Acute Heart Failure Case Studies
Figure 6. Chronic Heart Failure Case Studies
Figure 7. Heart Failure Treatment Report Years Considered
Figure 8. Global Heart Failure Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Heart Failure Treatment Market Share by Regions: 2020 VS 2026
Figure 10. Global Heart Failure Treatment Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Heart Failure Treatment Market Share by Players in 2019
Figure 13. Global Top Heart Failure Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Heart Failure Treatment Revenue in 2019
Figure 15. North America Heart Failure Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Heart Failure Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Heart Failure Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Heart Failure Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Heart Failure Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Heart Failure Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Heart Failure Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Pfizer Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 24. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Novartis Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 26. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Merck Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 30. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Johnson & Johnson Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 32. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AstraZeneca Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 34. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. GlaxoSmithKline Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 36. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Amgen Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 38. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bayer Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 40. BMS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. BMS Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 42. Cardiorentis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Cardiorentis Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 44. Cytokinetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Cytokinetics Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 46. Ono Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Ono Pharmaceuticals Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 48. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Mylan Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 50. NCPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. NCPC Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 52. Xinhua Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Xinhua Group Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 54. Xudong Haipu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Xudong Haipu Pharmaceutical Revenue Growth Rate in Heart Failure Treatment Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed